Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chemo-radiotherapy as Main Treatment Strategy for Rectal Cancer. Can we Provide a More Precise and Effective Treatment

NCT03619668 is registered in ClinicalTrials.gov with Aalborg University Hospital as lead sponsor.

NCT NCT03619668
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03619668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chemo-radiotherapy as Main Treatment Strategy for Rectal Cancer. Can we Provide a More Precise and Effective Treatment
Lead sponsor
Aalborg University Hospital
Phase
Observational
Overall status
Unknown status
Start date
June 29, 2018
Completion date
March 1, 2025
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced malignant neoplasm, rectal adenocarcinoma, rectal cancer